Published in Heart on July 01, 2002
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20
Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England. J Epidemiol Community Health (2004) 2.03
Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol (2005) 1.89
Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001. Heart (2003) 1.53
National trends in statin use by coronary heart disease risk category. PLoS Med (2005) 1.41
Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart (2006) 1.19
Gender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary care. BMC Health Serv Res (2007) 1.11
How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England. Int J Equity Health (2007) 1.11
The use of lipid-lowering drugs across ethnic groups in the secondary prevention of ischaemic heart disease: analysis of cross-sectional surveys in England. Br J Gen Pract (2004) 1.10
Which doctors are influenced by a patient's age? A multi-method study of angina treatment in general practice, cardiology and gerontology. Qual Saf Health Care (2007) 1.09
Cardiorespiratory risk factors as predictors of 40-year mortality in women and men. Heart (2009) 1.08
Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance. BMC Public Health (2010) 0.98
Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service Framework. J Public Health (Oxf) (2005) 0.95
Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001. Eur J Clin Pharmacol (2004) 0.92
Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol (2005) 0.91
Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need. Int J Equity Health (2005) 0.90
Patients with acute coronary syndrome should start a statin while still in hospital. Heart (2002) 0.90
Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study. J Public Health (Oxf) (2007) 0.87
Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients. Int J Equity Health (2008) 0.85
Socioeconomic and ethnic differences in use of lipid-lowering drugs after deregulation of simvastatin in the UK: the Whitehall II prospective cohort study. Atherosclerosis (2010) 0.83
Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort. Br J Gen Pract (2012) 0.82
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2008) 0.82
Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study. BMC Public Health (2012) 0.82
Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial. Can J Cardiol (2007) 0.80
Inequalities in access to care for patients with ischaemic heart disease. Br J Gen Pract (2004) 0.77
The use of cholesterol-lowering medications after coronary revascularization. CMAJ (2003) 0.76
Neighborhood socioeconomic characteristics and statin medication in patients with myocardial infarction: a Swedish nationwide follow-up study. BMC Cardiovasc Disord (2016) 0.75
Evaluating quality and its determinants in lipid control for secondary prevention of heart disease and stroke in primary care: a study in an inner London Borough. BMJ Open (2015) 0.75
Statins and their interactions with other lipid-modifying medications: safety issues in the elderly. Ther Adv Drug Saf (2012) 0.75
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
The use of statins: a case of misleading priorities? BMJ (1997) 13.35
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ (2001) 6.32
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart (1999) 2.69
Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ (2000) 2.57
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet (2001) 2.23
Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed? Br J Gen Pract (1997) 2.22
Time trend analysis and variations in prescribing lipid lowering drugs in general practice. BMJ (1998) 2.21
Inequalities in access to coronary angiography and revascularisation: the association of deprivation and location of primary care services. Br J Gen Pract (2000) 2.01
Use of statins in general practices, 1996-8: cross sectional study. BMJ (2000) 1.73
Age, sex and practice variations in the use of statins in general practice in England and Wales. J Public Health Med (2000) 1.60
Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances. J Hypertens (2001) 1.11
Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial. Am J Hypertens (1999) 0.98
Cigarette smoking in British men and selection for coronary artery bypass surgery. Heart (1996) 0.97
Lipid lowering drugs for patients who continue to smoke? Heart (2000) 0.82
Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ (1994) 9.81
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Influence of fathers' social class on cardiovascular disease in middle-aged men. Lancet (1996) 5.43
Prevalence of ischaemic heart disease in middle aged British men. Br Heart J (1984) 5.41
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Using data from the 1991 census. BMJ (1995) 3.63
Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet (1989) 3.51
Home visiting by general practitioners in England and Wales. BMJ (1996) 3.31
Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax (1998) 3.19
Cardiovascular risk factors in British children from towns with widely differing adult cardiovascular mortality. BMJ (1996) 3.14
Loss of employment and mortality. BMJ (1994) 3.06
Health of unemployed middle-aged men in Great Britain. Lancet (1982) 2.94
Early influences on blood pressure: a study of children aged 5-7 years. BMJ (1989) 2.90
Sociodemographic variables for general practices: use of census data. BMJ (1995) 2.90
Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol (2001) 2.85
The British Regional Heart Study 1975-2004. Int J Epidemiol (2004) 2.72
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart (1997) 2.65
Recall of diagnosis by men with ischaemic heart disease. Br Heart J (1984) 2.57
Explaining variation in hospital admission rates between general practices: cross sectional study. BMJ (1999) 2.56
Blood pressure in British children: associations with adult blood pressure and cardiovascular mortality. Lancet (1988) 2.51
Size at birth and blood pressure: cross sectional study in 8-11 year old children. BMJ (1997) 2.45
Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax (1997) 2.36
Twenty year follow-up of a cohort based in general practices in 24 British towns. J Public Health Med (2000) 2.34
Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ (1995) 2.31
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24
Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23
Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed? Br J Gen Pract (1997) 2.22
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
What factors are associated with physical activity in older people, assessed objectively by accelerometry? Br J Sports Med (2008) 2.07
Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia (2011) 2.06
Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies. Int J Obes (Lond) (2009) 2.05
Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol (1985) 2.01
Chronic exposure to outdoor air pollution and lung function in adults. Thorax (2009) 1.98
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96
A critical review of the effect of factory closures on health. Br J Ind Med (1991) 1.95
Validation of patient recall of doctor-diagnosed heart attack and stroke: a postal questionnaire and record review comparison. Am J Epidemiol (1998) 1.92
C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis (2000) 1.90
Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart (2007) 1.87
Passive exposure to tobacco smoke in children aged 5-7 years: individual, family, and community factors. BMJ (1994) 1.82
Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986. BMJ (2001) 1.81
The Dinamap 1846SX automated blood pressure recorder: comparison with the Hawksley random zero sphygmomanometer under field conditions. J Epidemiol Community Health (1992) 1.77
ABO blood group and ischaemic heart disease in British men. BMJ (1990) 1.76
The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord (1999) 1.72
Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ (1995) 1.72
Validity of a self-reported history of doctor-diagnosed angina. J Clin Epidemiol (1999) 1.71
Non-employment and changes in smoking, drinking, and body weight. BMJ (1992) 1.68
Do maternal and intrauterine factors influence blood pressure in childhood? Arch Dis Child (1992) 1.66
Relation of passive smoking as assessed by salivary cotinine concentration and questionnaire to spirometric indices in children. Thorax (1993) 1.65
North-south gradients in Britain for stroke and CHD: are they explained by the same factors? Stroke (2003) 1.63
Chronic manganese intoxication. Arch Neurol (1974) 1.61
Geographic variation in incidence of coronary heart disease in Britain: the contribution of established risk factors. Heart (2001) 1.60
Health and social precursors of unemployment in young men in Great Britain. J Epidemiol Community Health (1996) 1.60
Non-attendance at re-examination 20 years after screening in the British Regional Heart Study. J Public Health Med (2002) 1.58
Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax (1997) 1.55
Time trends in respiratory symptoms in childhood over a 24 year period. Arch Dis Child (1993) 1.55
Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation (1997) 1.54
Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation (2000) 1.53
Effect of fresh fruit consumption on lung function and wheeze in children. Thorax (1997) 1.53
Infections presenting for clinical care in early life and later risk of hay fever in two UK birth cohorts. Allergy (2008) 1.52
Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J (1986) 1.49
Serum urate and the risk of major coronary heart disease events. Heart (1997) 1.46
British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans. Diabet Med (2005) 1.46
Socio-economic determinants of casualty and NHS Direct use. J Public Health (Oxf) (2008) 1.46
Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia (2004) 1.46
D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45
Timing of routine immunisations and subsequent hay fever risk. Arch Dis Child (2005) 1.45
Do children who become autistic consult more often after MMR vaccination? Br J Gen Pract (2001) 1.44
Annual night visiting rates in 129 general practices in one family health services authority: association with patient and general practice characteristics. Br J Gen Pract (1995) 1.43
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart (1997) 1.42
Serum proteins and mortality. Lancet (1990) 1.41
Unemployment pre-dates symptoms of depression and anxiety resulting in medical consultation in young men. Int J Epidemiol (1999) 1.40
Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation (2005) 1.37
Alcohol intake in middle age and risk of cardiovascular disease and mortality: accounting for intake variation over time. Am J Epidemiol (2005) 1.36
Smoking cessation and the risk of stroke in middle-aged men. JAMA (1995) 1.35
Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children. Thorax (1998) 1.35
Short stature, lung function and risk of a heart attack. Int J Epidemiol (1989) 1.33
Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med (1998) 1.33
Inequalities in coronary revascularisation during the 1990s: evidence from the British regional heart study. Heart (2005) 1.32
Non-participation and mortality in a prospective study of cardiovascular disease. J Epidemiol Community Health (1987) 1.32
Chest pain on questionnaire and prediction of major ischaemic heart disease events in men. Eur Heart J (1998) 1.29
Do general practitioners influence the uptake of breast cancer screening? J Med Screen (1995) 1.29
Maternal cotinine level during pregnancy and birthweight for gestational age. Int J Epidemiol (1998) 1.29
Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children. Thorax (1998) 1.26
Biochemical measures in a population-based study: effect of fasting duration and time of day. Ann Clin Biochem (2002) 1.25
Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J (2004) 1.24
Adult height, stroke, and coronary heart disease. Am J Epidemiol (1998) 1.24